By Drug Target Review2024-02-07T12:00:50
Researchers found that resolvinT4 restores protective macrophage biological activities in rheumatoid arthritis patients.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-27T13:06:00Z
2023-07-11T16:13:06
Sponsored by Agilent
2023-07-04T09:00:08
Sponsored by SB Drug Discovery
2024-02-08T11:07:39
Sponsored by Samplix ApS
Site powered by Webvision Cloud